DPT · Class II · 21 CFR 870.2120

FDA Product Code DPT: Probe, Blood-flow, Extravascular

Leading manufacturers include Rwd Life Science Co., Ltd..

48
Total
48
Cleared
183d
Avg days
1978
Since
Growing category - 1 submissions in the last 2 years vs 0 in the prior period
Review times increasing: avg 245d recently vs 181d historically

FDA 510(k) Cleared Probe, Blood-flow, Extravascular Devices (Product Code DPT)

48 devices
1–24 of 48

About Product Code DPT - Regulatory Context

510(k) Submission Activity

48 total 510(k) submissions under product code DPT since 1978, with 48 receiving FDA clearance (average review time: 183 days).

Submission volume has increased in recent years - 1 submissions in the last 24 months compared to 0 in the prior period - suggesting growing market activity in this device classification.

FDA Review Time

Recent submissions under DPT have taken an average of 245 days to reach a decision - up from 181 days historically. Manufacturers should account for longer review timelines in current project planning.

DPT devices are reviewed by the General & Plastic Surgery panel. Browse all General & Plastic Surgery devices →